This drug is a major cause of drug-induced [[hypoglycemia]]. The risk is greater than with other [[sulfonylurea]]s.<ref>{{cite journal|last=Gangji|first=A. S.|author2=Cukierman, T. |author3=Gerstein, H. C. |author4=Goldsmith, C. H. |author5= Clase, C. M. |title=A Systematic Review and Meta-Analysis of Hypoglycemia and Cardiovascular Events: A comparison of glyburide with other secretagogues and with insulin|journal=Diabetes Care|date=1 February 2007|volume=30|issue=2|pages=389–394|doi=10.2337/dc06-1789 |pmid=17259518}}</ref>  Cholestatic [[jaundice]] is noted.

 


 
Glibenclamide may be not recommended in those with G6PD deficiency, as it may cause acute haemolysis.<ref name="pmid8562390">{{cite journal |vauthors=Meloni G, Meloni T | title = Glyburide-induced acute haemolysis in a G6PD-deficient patient with NIDDM | journal = Br. J. Haematol. | volume = 92 | issue = 1 | pages = 159–60 |date=January 1996 | pmid = 8562390 | doi = 10.1046/j.1365-2141.1996.275810.x| url = }}</ref>

 

